メールサービス キャンペーン : 期間中に新規登録や配信希望カテゴリの変更等をされた方に、ご用意した無料レポートを提供しております。 新規登録 / 登録内容変更

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

CRO (開発業務受託機関) の世界市場予測 2023年:創薬研究・CMC (化学、製造、品質管理)・前臨床サービス・臨床研究サービス・ラボサービス

Contract Research Organization Services (CROs) Market by Type (Discovery, CMC, Preclinical, Clinical Research, Laboratory Services), Therapeutic Area (Oncology, CNS, Cardiovascular), End User (Pharmaceuticals & Medical Device) - Global Forecast to 2023

発行 MarketsandMarkets 商品コード 379870
出版日 ページ情報 英文 262 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.89円で換算しております。
Back to Top
CRO (開発業務受託機関) の世界市場予測 2023年:創薬研究・CMC (化学、製造、品質管理)・前臨床サービス・臨床研究サービス・ラボサービス Contract Research Organization Services (CROs) Market by Type (Discovery, CMC, Preclinical, Clinical Research, Laboratory Services), Therapeutic Area (Oncology, CNS, Cardiovascular), End User (Pharmaceuticals & Medical Device) - Global Forecast to 2023
出版日: 2018年02月02日 ページ情報: 英文 262 Pages
概要

世界におけるCRO (開発業務受託機関) サービス市場の規模は、2018年の391億3,000万米ドルから2023年までに563億4,000万米ドルへ、7.9%のCAGR (年間複合成長率) で拡大すると予測されています。同市場の成長は主にR&D活動のアウトソーシングの増加、および臨床試験数の増加によるものです。しかし、CROサービス市場における競合の激化は、同市場で活動する企業にとって大きな課題のひとつとなっています。。

当レポートでは、世界におけるCRO (開発業務受託機関) 市場を取り上げ、市場の概要、市場発展促進・阻害要因、市場における課題および機会を概括し、タイプ・治療領域・エンドユーザー・地域別に市場の現状と見通しについて調査分析するとともに、競合環境、主要企業のプロファイルをまとめ、お届けいたします。

CRO SERVICES MARKET

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • CROサービス市場概要
  • アジア太平洋:CROサービス市場、種類・国別
  • CROサービス市場:地域の成長機会
  • CROサービス市場:地域ミックス
  • CROサービス市場:新興 vs. 先進諸国

第5章 市場概要

  • イントロダクション
  • 市場ダイナミクス
    • 市場成長促進因子
    • 市場機会
    • 市場課題
  • 産業動向
    • CRO産業における統合の増加
    • 新興市場への臨床試験のアウトソーシングの増加
    • 新技術の導入

第6章 CROサービス市場:タイプ別

  • イントロダクション
  • 臨床研究サービス
    • フェーズI臨床研究サービス
    • フェーズII臨床研究サービス
    • フェーズIII臨床研究サービス
    • フェーズIV臨床研究サービス
  • 早期開発サービス
    • 創薬研究
    • CMC (化学、製造、品質管理)
    • 前臨床サービス
  • ラボサービス
    • バイオ分析試験サービス
    • 分析試験サービス
  • コンサルティングサービス

第7章 世界のCROサービス市場:治療領域別

  • イントロダクション
  • 感染症
  • 中枢神経系 (CNS) 疾患
  • 免疫疾患
  • 心血管疾患
  • 呼吸器疾患
  • 糖尿病
  • その他の治療領域

第8章 CROサービス市場:エンドユーザー別

  • イントロダクション
  • 医薬品・バイオ医薬品企業
  • 医療機器企業
  • 大学機関

第9章 CROサービス市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合環境

  • 概要
  • 市場シェア分析
  • 競合状況

第11章 企業プロファイル

  • IQVIA
  • LABCORP
  • PAREXEL
  • PRA HEALTH SCIENCES
  • PPD
  • ICON PLC
  • SYNEOS HEALTH
  • WUXI PHARMATECH
  • CHARLES RIVER
  • MEDPACE HOLDINGS
  • SGS
  • ENVIGO
  • MPI RESEARCH

第12章 付録

目次
Product Code: PH 4672

"The Contract Research Organization (CRO) services market is projected to grow at a CAGR of 7.6% between 2018 and 2023."

The CRO services market is expected to reach USD 56.34 billion by 2023 from USD 39.13 billion in 2018, at a CAGR of 7.6%. Increased outsourcing of R&D activities and increasing number of clinical trials are some of the major factors driving the growth of this market. However, intense competition in the CRO services market is one of the major challenges for the players operating in the CRO services market.

"Laboratory services segment to witness the highest growth rate during the forecast period."

Among the CRO services, the laboratory services segment is expected to register the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing number of pipeline drugs and growing outsourcing of laboratory services by pharmaceutical and biopharmaceutical companies.

"Oncology segment to grow at the highest CAGR from 2018 to 2023."

Oncology segment is expected to register the highest CAGR during the forecast period. The increasing number of clinical trials and rising prevalence of cancer worldwide are the major factors supporting its growth during the forecast period.

"APAC to witness the highest growth rate during the forecast period."

The Asia Pacific region is expected to witness the highest CAGR during the forecast period, owing the rapid growth in the pharmaceutical and biopharmaceutical industry, low cost of clinical trials, rising number of CROs, and favorable government policies in the region.

Break primary participants:

  • By Company Type - Tier 1: 21%, Tier 2-26%, and Tier 3-53%
  • By Designation - C Level: 32%, Director Level: 26%, and Others: 42%
  • By Region - North America: 26%, Europe: 35%, Asia Pacific: 20%, Latin America: 11%, and the Middle East & Africa: 8%

Research Coverage:

The report analyzes the various CRO services and their adoption patterns in the market. It aims at estimating the market size and future growth potential of the global CRO services market for different segments such as type, therapeutic area, end user, and region. The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help garner a greater share. Firms purchasing the report could use any one or combination of the below-mentioned strategies for strengthening their market positions.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the service portfolios offered by the top players in the CRO services market
  • Service Launch/Innovation: Detailed insights on new service launches in the CRO services market
  • Market Development: Comprehensive information about lucrative emerging markets, by type, therapeutic area, end user, and region
  • Market Diversification: Exhaustive information about new services, growing geographies, recent developments in the CRO services market
  • Competitive Assessment: In-depth assessment of growth strategies, services, and manufacturing capabilities of leading players in the CRO services market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
    • 2.2.1. BOTTOM-UP APPROACH
    • 2.2.2. TOP-DOWN APPROACH
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. CRO SERVICES MARKET OVERVIEW
  • 4.2. ASIA PACIFIC: CRO SERVICES MARKET, BY TYPE AND COUNTRY
  • 4.3. CRO SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4. CRO SERVICES MARKET: GEOGRAPHIC MIX
  • 4.5. CRO SERVICES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Growing R&D expenditure
      • 5.2.1.2. Increased outsourcing of R&D activities
      • 5.2.1.3. Increasing number of clinical trials
    • 5.2.2. OPPORTUNITIES
      • 5.2.2.1. Growth in the biosimilars and biologics markets
      • 5.2.2.2. Rising demand for specialized testing services
      • 5.2.2.3. Emerging Asian markets
    • 5.2.3. CHALLENGES
      • 5.2.3.1. Intense competition in the cro services market
      • 5.2.3.2. Shortage of skilled professionals
  • 5.3. INDUSTRY TRENDS
    • 5.3.1. GROWING CONSOLIDATION IN THE CRO INDUSTRY
    • 5.3.2. INCREASING OUTSOURCING OF CLINICAL TRIALS TO EMERGING MARKETS
    • 5.3.3. ADOPTION OF NEW TECHNOLOGIES

6. CRO SERVICES MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. CLINICAL RESEARCH SERVICES
    • 6.2.1. PHASE I CLINICAL RESEARCH SERVICES
    • 6.2.2. PHASE II CLINICAL RESEARCH SERVICES
    • 6.2.3. PHASE III CLINICAL RESEARCH SERVICES
    • 6.2.4. PHASE IV CLINICAL RESEARCH SERVICES
  • 6.3. EARLY-PHASE DEVELOPMENT SERVICES
    • 6.3.1. DISCOVERY STUDIES
    • 6.3.2. CHEMISTRY, MANUFACTURING, & CONTROL (CMC)
    • 6.3.3. PRECLINICAL SERVICES
      • 6.3.3.1. Pharmacokinetics/pharmacodynamics (PK/PD)
      • 6.3.3.2. Toxicology testing services
      • 6.3.3.3. Other preclinical services
  • 6.4. LABORATORY SERVICES
    • 6.4.1. BIOANALYTICAL TESTING SERVICES
    • 6.4.2. ANALYTICAL TESTING SERVICES
      • 6.4.2.1. Physical characterization
      • 6.4.2.2. Raw material testing
      • 6.4.2.3. Batch-release testing
      • 6.4.2.4. Stability testing
      • 6.4.2.5. Other analytical testing services
  • 6.5. CONSULTING SERVICES

7. GLOBAL CRO SERVICES MARKET, BY THERAPEUTIC AREA

  • 7.1. INTRODUCTION
  • 7.2. ONCOLOGY
  • 7.3. INFECTIOUS DISEASES
  • 7.4. CENTRAL NERVOUS SYSTEM (CNS) DISORDERS
  • 7.5. IMMUNOLOGICAL DISORDERS
  • 7.6. CARDIOVASCULAR DISEASES
  • 7.7. RESPIRATORY DISORDERS
  • 7.8. DIABETES
  • 7.9. OTHER THERAPEUTIC AREAS

8. CRO SERVICES MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
  • 8.3. MEDICAL DEVICE COMPANIES
  • 8.4. ACADEMIC INSTITUTES

9. CRO SERVICES MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. UK
    • 9.3.3. FRANCE
    • 9.3.4. ITALY
    • 9.3.5. SPAIN
    • 9.3.6. REST OF EUROPE
  • 9.4. ASIA PACIFIC
    • 9.4.1. CHINA
    • 9.4.2. JAPAN
    • 9.4.3. INDIA
    • 9.4.4. REST OF ASIA PACIFIC
  • 9.5. LATIN AMERICA
  • 9.6. MIDDLE EAST & AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. MARKET SHARE ANALYSIS
  • 10.3. COMPETITIVE SCENARIO
    • 10.3.1. AGREEMENTS, COLLABORATIONS, JOINT VENTURES, AND PARTNERSHIPS (2014-2017)
    • 10.3.2. SERVICE LAUNCHES (2014-2017)
    • 10.3.3. EXPANSIONS (2014-2017)
    • 10.3.4. ACQUISITIONS (2014-2017)

11. COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, SWOT Analysis, Mnm View)*

  • 11.1. IQVIA
  • 11.2. LABCORP
  • 11.3. PAREXEL
  • 11.4. PRA HEALTH SCIENCES
  • 11.5. PPD
  • 11.6. ICON PLC
  • 11.7. SYNEOS HEALTH
  • 11.8. WUXI PHARMATECH
  • 11.9. CHARLES RIVER
  • 11.10. MEDPACE HOLDINGS
  • 11.11. SGS
  • 11.12. ENVIGO
  • 11.13. MPI RESEARCH

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, Mnm View might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS
  • 12.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
  • TABLE 2: R&D EXPENDITURE & PERCENTAGE CHANGE, BY PHARMACEUTICAL COMPANY (2014-2016)
  • TABLE 3: INCREASED OUTSOURCING OF R&D ACTIVITIES TO DRIVE MARKET GROWTH
  • TABLE 4: LIST OF BIOLOGICAL LICENSE APPLICATION APPROVALS IN THE US, 2016
  • TABLE 5: CLINICAL STUDIES FOR BIOLOGIC & BIOSIMILAR MOLECULES (2017)
  • TABLE 6: GROWING BIOSIMILARS AND BIOLOGICS MARKETS TO PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES
  • TABLE 7: INTENSE COMPETITION IN THE CRO SERVICES MARKET IS A MAJOR CHALLENGE IN THE MARKET
  • TABLE 8: MAJOR MERGERS AND ACQUISITIONS IN CRO INDUSTRY (2013-2017)
  • TABLE 9: CRO SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 10: CRO SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 11: NUMBER OF REGISTERED AND RECRUITING CLINICAL STUDIES, BY LOCATION, 2017
  • TABLE 12: KEY CLINICAL RESEARCH SERVICES OFFERED BY PROMINENT PLAYERS
  • TABLE 13: CLINICAL RESEARCH SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 14: CLINICAL RESEARCH SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 15: COMPLETED PHASE II STUDIES FOR DIFFERENT THERAPEUTIC AREAS
  • TABLE 16: PHASE I CLINICAL RESEARCH SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 17: COMPLETED PHASE II STUDIES FOR DIFFERENT THERAPEUTIC AREAS
  • TABLE 18: PHASE II CLINICAL RESEARCH SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 19: COMPLETED PHASE III STUDIES FOR DIFFERENT THERAPEUTIC AREAS
  • TABLE 20: PHASE III CLINICAL RESEARCH SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 21: COMPLETED PHASE IV STUDIES FOR DIFFERENT THERAPEUTIC AREAS
  • TABLE 22: PHASE IV CLINICAL RESEARCH SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 23: KEY EARLY-PHASE DEVELOPMENT SERVICES OFFERED BY PROMINENT PLAYERS
  • TABLE 24: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 25: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 26: DISCOVERY STUDIES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 27: CHEMISTRY, MANUFACTURING, & CONTROL MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 28: PRECLINICAL SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 29: PRECLINICAL SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 30: PHARMACOKINETICS/PHARMACODYNAMICS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 31: TOXICOLOGY TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 32: OTHER PRECLINICAL SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 33: LABORATORY SERVICES: KEY SERVICES OFFERED BY PROMINENT PLAYERS
  • TABLE 34: LABORATORY SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 35: LABORATORY SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 36: BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 37: ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 38: ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 39: PHYSICAL CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 40: RAW MATERIAL TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 41: BATCH-RELEASE TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 42: STABILITY TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 43: OTHER ANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 44: CONSULTING SERVICES: KEY SERVICES OFFERED BY PROMINENT PLAYERS
  • TABLE 45: CONSULTING SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 46: GLOBAL NUMBER OF CLINICAL TRIALS IN DIFFERENT THERAPEUTIC AREAS, 2017
  • TABLE 47: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 48: CRO SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 49: LIST OF PIPELINE DRUGS FOR INFECTIOUS DISEASES (2016)
  • TABLE 50: CRO SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 51: LIST OF PIPELINE DRUGS FOR CNS DISORDERS (2016)
  • TABLE 52: CRO SERVICES MARKET FOR CNS DISORDERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 53: PREVALENCE OF PID, BY REGION, 2013 VS. 2015
  • TABLE 54: LIST OF PIPELINE DRUGS FOR IMMUNOLOGICAL DISORDERS (2016)
  • TABLE 55: CRO SERVICES MARKET FOR IMMUNOLOGICAL DISORDERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 56: LIST OF PIPELINE DRUGS FOR CARDIOVASCULAR DISEASES (2016)
  • TABLE 57: CRO SERVICES MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 58: LIST OF PIPELINE DRUGS FOR RESPIRATORY DISORDERS (2016)
  • TABLE 59: CRO SERVICES MARKET FOR RESPIRATORY DISORDERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 60: LIST OF PIPELINE DRUGS FOR DIABETES (2016)
  • TABLE 61: CRO SERVICES MARKET FOR DIABETES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 62: LIST OF PIPELINE DRUGS FOR OTHER THERAPEUTIC AREAS (2016)
  • TABLE 63: CRO SERVICES MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 64: CRO SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 65: NUMBER OF BIOPHARMACEUTICAL DRUGS IN DEVELOPMENT ACROSS THE GLOBE, 2016
  • TABLE 66: CRO SERVICES MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 67: CRO SERVICES MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 68: CRO SERVICES MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 69: CRO SERVICES MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 70: NORTH AMERICA: CRO SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 71: NORTH AMERICA: CRO SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 72: NORTH AMERICA: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 73: NORTH AMERICA: PRECLINICAL SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 74: NORTH AMERICA: CLINICAL RESEARCH SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 75: NORTH AMERICA: LABORATORY SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 76: NORTH AMERICA: ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 77: NORTH AMERICA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 78: NORTH AMERICA: CRO SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 79: TOTAL NUMBER OF CLINICAL TRIALS IN THE US (2017)
  • TABLE 80: US: CRO SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 81: US: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 82: US: PRECLINICAL SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 83: US: CLINICAL RESEARCH SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 84: US: LABORATORY SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 85: US: ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 86: US: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 87: US: CRO SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 88: CANADA: CRO SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 89: CANADA: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 90: CANADA: PRECLINICAL SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 91: CANADA: CLINICAL RESEARCH SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 92: CANADA: LABORATORY SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 93: CANADA: ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 94: CANADA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 95: CANADA: CRO SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 96: EUROPE: PHARMACEUTICAL R&D EXPENDITURE, BY COUNTRY, 2012 VS. 2014
  • TABLE 97: EUROPE: CRO SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 98: EUROPE: CRO SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 99: EUROPE: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 100: EUROPE: PRECLINICAL SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 101: EUROPE: CLINICAL RESEARCH SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 102: EUROPE: LABORATORY SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 103: EUROPE: ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 104: EUROPE: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 105: EUROPE: CRO SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 106: GERMANY: CRO SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 107: GERMANY: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 108: GERMANY: PRECLINICAL SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 109: GERMANY: CLINICAL RESEARCH SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 110: GERMANY: LABORATORY SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 111: GERMANY: ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 112: GERMANY: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 113: GERMANY: CRO SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 114: UK: CRO SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 115: UK: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 116: UK: PRECLINICAL SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 117: UK: CLINICAL RESEARCH SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 118: UK: LABORATORY SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 119: UK: ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 120: UK: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 121: UK: CRO SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 122: FRANCE: CRO SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 123: FRANCE: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 124: FRANCE: PRECLINICAL SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 125: FRANCE: CLINICAL RESEARCH SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 126: FRANCE: LABORATORY SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 127: FRANCE: ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 128: FRANCE: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 129: FRANCE: CRO SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 130: CLINICAL TRIALS IN ITALY (2013 VS. 2014)
  • TABLE 131: ITALY: CRO SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 132: ITALY: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 133: ITALY: PRECLINICAL SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 134: ITALY: CLINICAL RESEARCH SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 135: ITALY: LABORATORY SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 136: ITALY: ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 137: ITALY: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 138: ITALY: CRO SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 139: SPAIN: CRO SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 140: SPAIN: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 141: SPAIN: PRECLINICAL SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 142: SPAIN: CLINICAL RESEARCH SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 143: SPAIN: LABORATORY SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 144: SPAIN: ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 145: SPAIN: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 146: SPAIN: CRO SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 147: PHARMACEUTICAL R&D EXPENDITURE & PRODUCTION IN ROE COUNTRIES (2012 VS. 2014)
  • TABLE 148: ROE: CRO SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 149: ROE: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 150: ROE: PRECLINICAL SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 151: ROE: CLINICAL RESEARCH SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 152: ROE: LABORATORY SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 153: ROE: ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 154: ROE: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 155: ROE: CRO SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 156: TOTAL NUMBER OF CLINICAL TRIALS IN ASIA PACIFIC, BY THERAPEUTIC AREA, 2017
  • TABLE 157: ASIA PACIFIC: CRO SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 158: ASIA PACIFIC: CRO SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 159: ASIA PACIFIC: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 160: ASIA PACIFIC: PRECLINICAL SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 161: ASIA PACIFIC: CLINICAL RESEARCH SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 162: ASIA PACIFIC: LABORATORY SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 163: ASIA PACIFIC: ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 164: ASIA PACIFIC: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 165: ASIA PACIFIC: CRO SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 166: TOTAL NUMBER OF CLINICAL TRIALS IN CHINA, BY THERAPEUTIC AREA, 2017
  • TABLE 167: CHINA: CRO SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 168: CHINA: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 169: CHINA: PRECLINICAL SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 170: CHINA: CLINICAL RESEARCH SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 171: CHINA: LABORATORY SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 172: CHINA: ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 173: CHINA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 174: CHINA: CRO SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 175: JAPAN: CRO SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 176: JAPAN: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 177: JAPAN: PRECLINICAL SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 178: JAPAN: CLINICAL RESEARCH SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 179: JAPAN: LABORATORY SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 180: JAPAN: ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 181: JAPAN: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 182: JAPAN: CRO SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 183: TOTAL NUMBER OF CLINICAL TRIALS IN INDIA, BY THERAPEUTIC AREA, 2017
  • TABLE 184: INCREASE IN R&D EXPENDITURE OF TOP 5 INDIAN PHARMACEUTICAL COMPANIES (2010 VS. 2017)
  • TABLE 185: INDIA: CRO SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 186: INDIA: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 187: INDIA: PRECLINICAL SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 188: INDIA: CLINICAL RESEARCH SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 189: INDIA: LABORATORY SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 190: INDIA: ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 191: INDIA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 192: INDIA: CRO SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 193: TOTAL NUMBER OF CLINICAL TRIALS IN AUSTRALIA, SINGAPORE, & MALAYSIA, BY THERAPEUTIC AREA, 2017
  • TABLE 194: ROAPAC: CRO SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 195: ROAPAC: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 196: ROAPAC: PRECLINICAL SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 197: ROAPAC: CLINICAL RESEARCH SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 198: ROAPAC: LABORATORY SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 199: ROAPAC: ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 200: ROAPAC: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 201: ROAPAC: CRO SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 202: TOTAL NUMBER OF CLINICAL TRIALS IN LATIN AMERICA, BY THERAPEUTIC AREA, 2017
  • TABLE 203: LATIN AMERICA: CRO SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 204: LATIN AMERICA: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 205: LATIN AMERICA: PRECLINICAL SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 206: LATIN AMERICA: CLINICAL RESEARCH SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 207: LATIN AMERICA: LABORATORY SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 208: LATIN AMERICA: ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 209: LATIN AMERICA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 210: LATIN AMERICA: CRO SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 211: TOTAL NUMBER OF CLINICAL TRIALS IN THE MIDDLE EAST AND AFRICA, BY THERAPEUTIC AREA, 2017
  • TABLE 212: MIDDLE EAST AND AFRICA: CRO SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 213: MIDDLE EAST AND AFRICA: EARLY-PHASE DEVELOPMENT SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 214: MIDDLE EAST AND AFRICA: PRECLINICAL SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 215: MIDDLE EAST AND AFRICA: CLINICAL RESEARCH SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 216: MIDDLE EAST AND AFRICA: LABORATORY SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 217: MIDDLE EAST AND AFRICA: ANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 218: MIDDLE EAST AND AFRICA: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2016-2023 (USD MILLION)
  • TABLE 219: MIDDLE EAST AND AFRICA: CRO SERVICES MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 220: GROWTH STRATEGY MATRIX (2014-2017)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: DATA TRIANGULATION METHODOLOGY
  • FIGURE 4: CRO SERVICES MARKET, BY TYPE, 2018 VS. 2023 (USD BILLION)
  • FIGURE 5: CRO SERVICES MARKET, BY THERAPEUTIC AREA, 2018 VS. 2023 (USD BILLION)
  • FIGURE 6: CRO SERVICES MARKET, BY END USER, 2018 VS. 2023 (USD BILLION)
  • FIGURE 7: GEOGRAPHIC SNAPSHOT: CRO SERVICES MARKET
  • FIGURE 8: GROWING R&D EXPENDITURE AND INCREASE IN NUMBER OF CLINICAL TRIALS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 9: PHASE III SEGMENT WILL CONTINUE TO DOMINATE APAC CLINICAL RESEARCH SERVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 10: THE US DOMINATED THE CRO SERVICES MARKET IN 2017
  • FIGURE 11: NORTH AMERICA TO DOMINATE THE CRO SERVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 12: CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 13: CONTRACT RESEARCH ORGANIZATION (CRO) SERVICES MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 14: NUMBER OF NEW CHEMICAL OR BIOLOGICAL ENTITIES (1997-2016)
  • FIGURE 15: TOTAL NUMBER OF REGISTERED STUDIES (2005-2017)
  • FIGURE 16: TOTAL NUMBER OF NEW MOLECULAR ENTITY (NME) AND NEW BIOLOGIC LICENSE APPLICATION (BLA) FILINGS AND APPROVALS IN THE US, 2006-2015
  • FIGURE 17: KEY TRENDS IN THE CRO SERVICES MARKET
  • FIGURE 18: CLINICAL RESEARCH SERVICES SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL CRO SERVICES MARKET BY 2023
  • FIGURE 19: COMPARATIVE ANALYSIS OF CLINICAL TRIALS OVER THE YEARS (2010-2016)
  • FIGURE 20: BIOPHARMACEUTICAL DRUGS UNDER DEVELOPMENT, BY THERAPEUTIC AREA, 2016
  • FIGURE 21: PHASES OF DRUG DISCOVERY STUDIES
  • FIGURE 22: ONCOLOGY SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL CRO SERVICES MARKET BY 2023
  • FIGURE 23: WORLDWIDE CANCER INCIDENCE AND MORTALITY (2012-2025)
  • FIGURE 24: TOTAL NUMBER OF CLINICAL TRIALS FOR ONCOLOGY (2017)
  • FIGURE 25: DIABETES PREVALENCE, BY COUNTRY, 2015 (MILLION INDIVIDUALS)
  • FIGURE 26: PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES SEGMENT TO DOMINATE THE CRO SERVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 27: R&D SPENDING OF PHRMA MEMBER COMPANIES, 1980-2015
  • FIGURE 28: CLINICAL STUDIES FOR MEDICAL DEVICES (2017)
  • FIGURE 29: CRO SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • FIGURE 30: TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA (2017)
  • FIGURE 31: NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 32: PHARMACEUTICAL R&D EXPENDITURE IN THE US (1990-2014)
  • FIGURE 33: EUROPE: MARKET SNAPSHOT
  • FIGURE 34: ASIA PACIFIC: MARKET SNAPSHOT
  • FIGURE 35: KEY DEVELOPMENTS IN THE CRO SERVICES MARKET, 2014-2017
  • FIGURE 36: GLOBAL CRO SERVICES MARKET SHARE, BY KEY PLAYER, 2017
  • FIGURE 37: IQVIA: COMPANY SNAPSHOT
  • FIGURE 38: LABCORP: COMPANY SNAPSHOT
  • FIGURE 39: PAREXEL: COMPANY SNAPSHOT
  • FIGURE 40: PRA HEALTH SCIENCES: COMPANY SNAPSHOT
  • FIGURE 41: ICON PLC: COMPANY SNAPSHOT
  • FIGURE 42: INC RESEARCH HOLDINGS: COMPANY SNAPSHOT
  • FIGURE 43: WUXI PHARMATECH: COMPANY SNAPSHOT
  • FIGURE 44: CHARLES RIVER: COMPANY SNAPSHOT (2016)
  • FIGURE 45: MEDPACE HOLDINGS: COMPANY SNAPSHOT
  • FIGURE 46: SGS: COMPANY SNAPSHOT
Back to Top